ABOUT VISTA PARTNERS

Vista Partners offers free, exclusive insight and research on the Dow 30 and Select Emerging Growth companies....

Browse Latest Coverage Learn More

Stay informed. Stay Competitive.

Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly, and quarterly investing ideas, strategies, and market insights.





We value your privacy and will never share your information. Click here to learn more about all the great features offered in our newsletter.

The Latest

Vista Current Coverage

A Growing List of Inspirational Quotes For Success!

We believe it is necessary to continue to inspire all to be their personal best in life and in investing. We also believe that keeping inspired and learning from others is an essential element to building long-term financial and emotional wealth. With this in mind, we...

ASH MEETING UPDATE: Fate Therapeutics Presents Off-the-Shelf CAR T & NK Cell Cancer Immunotherapy Pipeline (Shares Hit New All-Time High)

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company is pioneering the development of off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology pipeline is...

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD